Benzinga's M&A Chatter for Tuesday January 8, 2013

The following are the M&A deals, rumors and chatter circulating on Wall Street for Tuesday January 8, 2013: Vivus CEO Reportedly Says Acquisition is 'Inevitable' CEO Comments:
Vivus VVUS CEO Leland Wilson, talking to Deal Reporter at the J.P. Morgan Healthcare Conference in San Francisco, said partnership talks have been ongoing and a deal could be reached by year end. Wilson reportedly said a takeover is "inevitable", and said it's a matter "of when and at what price." Vivus shares traded as high as $15.12 on the report, but closed down 3% at $14.43 on twice average volume. Hearing Renewed Chatter of Icahn Stake in Research in Motion The Rumor:
Shares of Research in Motion RIMM surged higher in early trading on Tuesday, on unconfirmed chatter that investor Carl Icahn was going to take a significant stake in the Blackberry maker. On November 13, 2012, another unconfirmed report had Icahn leading a group of investors to buy RIMM for $13 per share. A spokesperson for Research in Motion declined comment on the rumor. Research in Motion closed at $11.91 Tuesday, a loss of $0.04 on average volume. Hearing Unconfirmed Chatter Google Could Bid for Virnetx Holding The Rumor:
Hearing unconfirmed market chatter that Google GOOG could bid $50 per share to acquire Virnetx Holding VHC in order to obstruct Apple's AAPL court case and/or settlement talks. A spokesperson for Google declined comment on the rumor. A Virnetx spokesperson was not available for comment. Virnetx Holding closed at $33.49 Tuesday, a gain of 1.5% for the day on average volume. Hearing Illumina Withdraws Bid for Complete Genomics The Offer:
Illumina ILMN reportedly has withdrawn its bid to acquire Complete Genomics GNOM, according to sources. Illumina had bid $3.30 to acquire Complete Genomics. That offer was rejected by GNOM's Board of Directors in November 2012. On Monday, BGI-Shenzhen subsidiary Beta Acquisition Corporation, extended its all-cash tender offer to acquire Complete Genomics for $3.15 per share, till January 11, 2013. Complete Genomics closed at $3.15 Tuesday, a loss of 1.5% for the day on 8.5 times average volume. Detwiler Note Says True Religion Deal Less Likely Now The Analyst Note:
A note from Detwiler Tuesday said not to expect an acquisition of True Religion TRLG to be announced in the short-term. It cited poor holiday sales as a reason to doubt a deal could be done at all. True Religion began a strategic review process on October 10, 2012. Deal Reporter reported on December 3 that private equity firms were losing interest. True Religion Apparel closed at $24.54 Tuesday, a loss of 3.5% on higher than average volume. Dish Offers $3.30/Share for Clearwire The Offer:
DISH Network DISH confirmed Tuesday that it has formally approached Clearwire Corporation CLWR with respect to a potential strategic transaction on terms as generally outlined in the Clearwire release, including an offer to purchase all of the Clearwire common shares at $3.30. Clearwire confirmed that it has received the unsolicited, non-binding proposal from DISH Network. Sprint S announced on December 17, 2012 that it had entered into a definitive agreement to acquire the approximately 50 percent stake in Clearwire it does not currently own for $2.97 per share. Clearwire closed at $2.92 Tuesday, but traded at $3.15 after the Dish offer was announced.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Long IdeasNewsShort IdeasRumorsM&AGlobalAfter-Hours CenterMoversTrading Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!